When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ADMA - ADMA Bio on go to launch Bivigam in U.S. for antibody production disorder
ADMA Biologics Inc
The FDA has approved ADMA Biologics' (NASDAQ:ADMA) Prior Approval Supplement for BIVIGAM (immune globulin intravenous (human), 10% liquid) for its optimized intravenous immune globulin manufacturing process.
More news on: ADMA Biologics, Inc., Healthcare stocks news, Stocks on the move,